LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
RETRACTION article
Retraction: LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT
Provisionally accepted- Frontiers Media SA, Lausanne, Switzerland
Keywords: lysyl-oxidase-like-2, epithelial-to-mesenchymal transition, temozolomide, Autophagy, Glioma
Received: 02 Aug 2024; Accepted: 13 Aug 2024.
Copyright: © 2024 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.